Monday morning trading has started off with an unfamiliar name on the list of the top 10 penny stocks; Advaxis Inc. (OTC: ADXS). ADXS is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. In April 2012, the Company’s ADXS-HPV was chosen as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
Looking for Hot Penny Stocks? Click here and get Alerts on the Best Penny Stocks FREE.
TOP 10 Most Active OTC Penny Stocks
| Symbol | Price | Pct Chg | $ Volume | Volume | Trades |
|---|---|---|---|---|---|
| GWBU | 1.83 | +0.55% | 1,164,473 | 633,431 | 416 |
| DOMK | 2.81 | +7.25% | 258,202 | 95,950 | 84 |
| BRFH | 0.939 | +2.07% | 161,415 | 170,770 | 51 |
| GGSM | 0.151 | +3.42% | 57,117 | 364,467 | 50 |
| ONVO | 6.01 | +15.13% | 204,865 | 31,371 | 45 |
| AGRT | 0.56 | -1.74% | 55,832 | 97,844 | 39 |
| ADXS | 0.101 | +3.06% | 41,002 | 405,745 | 39 |
| IPRC | 0.31 | 0.00% | 26,192 | 84,525 | 34 |
| ICPA | 0.038 | +15.15% | 16,091 | 455,429 | 31 |
| AAMRQ | 0.465 | +0.87% | 46,818 | 101,332 | 30 |
ADXS closed strong on Friday in antcipation of their clinical trials update at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL which is going on right now! See the press release here.
ADXS could easily double or even triple on Monday from its current levels after their expected positive results from their clinical studies of ADXS-HPV!
It wouldn’t be surprising if ADXS broke through these 3 technical levels:
0.2908: Price Crosses 9-18 Day Moving Average
0.3741: Price Crosses 9-40 Day Moving Average
0.5256: Price Crosses 18-40 Day Moving Average
This is a huge industry and the forefront against one of the top enemies we have: Cancer. The American Cancer Society estimates that there will be about 12,170 newly diagnosed cervical cancer cases in the U.S. in 2012. About 500,000 patients per year are diagnosed with high grade CIN (2-3), the predecessor condition to cervical cancer.
In 2009, the CDC reported that about 45% of women aged 20 to 24 had HPV. HPV causes a number of different types of cancer. The same types of genital HPV that cause cervical cancer (HPV-16, HPV-18) cause about 8 out of 10 squamous cell anal cancers. In addition, nearly half of cancers of the vulva and about 7 out of 10 vaginal cancers are HPV-related. Some other genital cancers (cancers of the penis and urethra) and some head and neck cancers (mostly the throat, tongue, and tonsils) are also related to high-risk types of HPV.
Bottom Line: Get ADXS on the list of penny stocks to watch. It speaks volumes when you win the award for the Best Therapeutic Vaccine from Novartis when you’re close to finding a solution to cervical cancer and being recognized by your peers in such a widely competitive industry.
Here is your opportunity to subscribe to the most elite penny stock newsletter.
Sign up with your email address now & get ready to make HUGE PROFITS on stocks that RUN.
(We are 100% Anti-Spam and will never rent or sell your information)
ShareJUN
